SKI Market

Indian Indices

Sensex

85,567.48 638.12
( 0.75%)

Global Indices

Nasdaq

48,160.46 187.60
(0.39%)

Dow Jones

6,855.87 60.11
(0.88%)

Hang Seng

49,620.18 618.68
(1.26%)

Nikkei 225

9,885.23 47.46
(0.48%)

Forex

USD-INR

90.25 -0.22
(-0.24%)

EUR-INR

105.87 -0.28
(-0.27%)

GBP-INR

120.72 -0.26
(-0.21%)

JPY-INR

0.58 0.00
(-0.44%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5600262

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.57

122538.89

EPS(TTM)

Face Value()

Div & Yield %

64.35

1.05

Back

Cipla consolidated net profit rises 3.73% in the September 2025 quarter

Oct 30,2025

Net profit of Cipla rose 3.73% to Rs 1351.17 crore in the quarter ended September 2025 as against Rs 1302.53 crore during the previous quarter ended September 2024. Sales rose 6.98% to Rs 7447.42 crore in the quarter ended September 2025 as against Rs 6961.22 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	7447.42	6961.22	7
OPM %	25.44	27.09	-
PBDT	2150.52	2060.80	4
PBT	1853.53	1789.06	4
NP	1351.17	1302.53	4

85,567.48 638.12 ( 0.75%)

48,160.46 187.60 (0.39%)

6,855.87 60.11 (0.88%)

49,620.18 618.68 (1.26%)

9,885.23 47.46 (0.48%)

90.25 -0.22 (-0.24%)

105.87 -0.28 (-0.27%)

120.72 -0.26 (-0.21%)

0.58 0.00 (-0.44%)